Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Anesthesia Induction in CABG
NCT05423951Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in general anesthesia (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Mean Arterial Pressure-time integral at 10 minutes. Started Jul 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05423951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05423951.